A. Nehme et al., Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells, BR J CANC, 84(11), 2001, pp. 1571-1576
We report that all-trans retinoic acid (ATRA) enhanced the toxicity of doce
taxel against DU145 and LNCaP prostate cancer cells, and that the nature of
the interaction between ATRA and docetaxel was highly synergistic. Docetax
el-induced apoptotic cell death was associated with phosphorylation and hen
ce inactivation of Bcl-2. ATRA enhanced docetaxel-induced apoptosis and com
bined treatment with ATRA and docetaxel resulted in down-regulation of Bcl-
2. Docetaxel caused phosphorylation and hence inactivation of cdc2 kinase r
esulting in G2/M arrest. ATRA inhibited docetaxel-induced phosphorylation o
f cdc2 resulting in activation of cdc2 kinase and partial reversal of the G
2/M arrest. ATRA also inhibited docetaxel-induced activation of MAPK indica
ting that the effects of docetaxel and ATRA on cdc2 phosphorylation are dep
endent on MAPK. We conclude that ATRA synergistically enhances docetaxel to
xicity by down-regulating Bcl-2 expression and partially reverses the docet
axel-induced G2/M arrest by inhibiting docelaxel-induced cdc2 phosphorylati
on in a pathway that is dependent on MAPK. (C) 2001 Cancer Research Campaig
n.